Sputnik V demonstrates strong protection against Omicron variant
Previous studies also demonstrated additional significant strengthening of protection against Omicron by Sputnik Light…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Gamaleya Center
RDIF and Morepen Laboratories announce test batch manufacturing of Sputnik V in India
The first batch will be shipped to the Gamaleya Center for the quality control
Sputnik V vaccine efficacy is 91.4 per cent: RDIF, Gamaleya Center
Based on the data obtained at the third control point, the Gamaleya Center will create a report that will be used to submit for…
Sputnik V vaccine shows 92 per cent efficacy in ongoing phase III trials in Russia
The confirmation is based on the first interim data from the double-blind, randomized, placebo-controlled Phase III clinical…